Placeholder Banner

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

WHAT: Roundtable discussion about the life sciences landscape, including the industry’s economic impact on Pennsylvania, the value of innovation, bioscience education opportunities, NIH funding and research best practices. Rep. Charlie Dent and Hon. Jim Greenwood to deliver remarks

WHO:
• Rep. Charlie Dent (R-PA-15)
• Hon. Jim Greenwood, President & CEO, BIO; former PA Congressman
• Mr. Craig Tucker, Vice President, PA BIO • Dr. Keri Donaldson, Founder, Prescient Medicine
• Dr. Ralf Brandt, CEO & Managing Director, vivoPharm
• Dr. Kent Vrana, Professor & Chair, Penn State Dept. of Pharmacology
• Dr. Mel Billingsley, President & CEO, Life Sciences Greenhouse of Central PA
• Ms. Caitlin Orr, Project Coordinator, Hershey Center for Applied Research
• Mr. Nick Magallanes, Director Federal Government Relations, BIO

WHEN: Tuesday, August 23, 2016, 1:30 to 2:30 p.m. (Eastern Time Zone)

WHERE:
Hershey Center for Applied Research
Room 1103
1214 Research Boulevard
Hummelstown, PA 17036  


https://www.bio.org/sites/default/files/SP_Pennsylvania_0.pdf

 

Discover More
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…